about
Allelic Variation in CXCL16 Determines CD3+ T Lymphocyte Susceptibility to Equine Arteritis Virus Infection and Establishment of Long-Term Carrier State in the StallionHost-inducible immunogenic sphingomyelinase-like protein, Lk73.5, of Leptospira interrogans.Equine arteritis virus does not induce interferon production in equine endothelial cells: identification of nonstructural protein 1 as a main interferon antagonist.Discovery of a small arterivirus gene that overlaps the GP5 coding sequence and is important for virus production.Equine Arteritis Virus Uses Equine CXCL16 as an Entry ReceptorEquine arteritis virus elicits a mucosal antibody response in the reproductive tract of persistently infected stallions.Equine Arteritis Virus Has Specific Tropism for Stromal Cells and CD8+ T and CD21+ B Lymphocytes but Not for Glandular Epithelium at the Primary Site of Persistent Infection in the Stallion Reproductive Tract.Complex interactions between the major and minor envelope proteins of equine arteritis virus determine its tropism for equine CD3+ T lymphocytes and CD14+ monocytes.Identification and Expression Analysis of Zebrafish (Danio rerio) E-Selectin during Embryonic Development.Detection of equine arteritis virus by two chromogenic RNA in situ hybridization assays (conventional and RNAscope(®)) and assessment of their performance in tissues from aborted equine fetuses.Conserved arginine residues in the carboxyl terminus of the equine arteritis virus E protein may play a role in heparin binding but may not affect viral infectivity in equine endothelial cells.Development and characterization of an infectious cDNA clone of the modified live virus vaccine strain of equine arteritis virus.Persistent equine arteritis virus infection in HeLa cells.Immunisation of mares with binding domains of toxins A and B of Clostridium difficile elicits serum and colostral antibodies that block toxin binding.
P2860
Q28588626-106DA924-3244-45FF-8305-344D13913DF4Q31037865-3DF15746-F3F5-43B5-9701-126246C05F0AQ33748361-8762D8B2-4B99-45E2-8CF8-0F93FA1E2B3CQ35114649-F337995E-8E36-4853-9CAE-181001C8DE17Q36694094-D897450C-7B1E-4C11-93E4-819AFF4C6A26Q40081016-D8709BF0-C65C-46B0-BD70-CC2BC903ACE3Q40235584-F1BDF33F-42E8-450C-A54B-F894FC46D75EQ40341824-17FB746E-A3C5-4AE6-B6AE-1D94C848B0C0Q40424167-0F543E91-E788-4825-9A51-5E2A2564AB2EQ40569796-7F9A17A4-79D1-4001-B1ED-08FA81DB5B63Q40842535-AA4C5A70-C7D2-4038-B8A1-0E682BD28A4EQ42270187-5C9B5B69-CEB4-4D34-A6E6-521870C2D259Q42406974-9913B68E-7A60-4E55-9888-42E5A9B73147Q54321930-821C566D-63F3-4B1F-ACEB-CD16B140EDC7
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Characterization of equine E-selectin.
@en
Characterization of equine E-selectin.
@nl
type
label
Characterization of equine E-selectin.
@en
Characterization of equine E-selectin.
@nl
prefLabel
Characterization of equine E-selectin.
@en
Characterization of equine E-selectin.
@nl
P2093
P2860
P1433
P1476
Characterization of equine E-selectin.
@en
P2093
B E McLaughlin
C D Demaula
J F Hedges
N J MacLachlan
P2860
P304
P356
10.1046/J.1365-2567.2001.01262.X
P577
2001-08-01T00:00:00Z